Honokiol Ameliorates Post-Myocardial Infarction Heart Failure Through Ucp3-Mediated Reactive Oxygen Species Inhibition

Post-myocardial infarction heart failure (post-MI HF) is one of the leading global causes of death, and current prevention and treatment methods still cannot avoid the increasing incidence. Honokiol (HK) has previously been reported to improve myocardial ischemia/reperfusion injury and reverse myoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jianyu, Tang, Minghai, Li, Tao, Su, Zhengying, Zhu, Zejiang, Dou, Caixia, Liu, Yan, Pei, Heying, Yang, Jianhong, Ye, Haoyu, Chen, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899544/
https://www.ncbi.nlm.nih.gov/pubmed/35264952
http://dx.doi.org/10.3389/fphar.2022.811682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899544/
https://www.ncbi.nlm.nih.gov/pubmed/35264952
http://dx.doi.org/10.3389/fphar.2022.811682

Ejemplares similares